Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing the risks for hereditary cancers; BRACAnalysis CDx Germline Companion Diagnostic Test, a DNA sequencing test to help determine the therapy for patients with metastatic breast, ovarian, metastatic pancreatic, or metastatic prostate cancer with deleterious or suspected deleterious germline BRCA variants; and MyChoice CDx Companion Diagnostic Test, a tumor test that determines homologous recombination deficiency status in patients with ovarian cancer. The company also offers Prolaris Prostate Cancer Prognostic Test, a RNA expression tumor analysis for assessing the aggressiveness of prostate cancer; EndoPredict Breast Cancer Prognostic Test, a RNA expression test for assessing the aggressiveness of breast cancer; Precise Tumor, a solution for precision oncology; and Prequel Prenatal Screen, a non-invasive prenatal screening test conducted using maternal blood to screen for severe chromosomal disorders in a fetus. In addition, it provides Foresight Carrier Screen, a prenatal test for future parents to assess their risk of passing on a recessive genetic condition to their offspring; and GeneSight Psychotropic Mental Health Medication Test, a DNA genotyping test to aid psychotropic drug selection for patients suffering from depression, anxiety, ADHD, and other mental health conditions. Myriad Genetics, Inc. has a strategic collaboration with Illumina, Inc. and Intermountain Precision Genomics for an offering of germline and somatic tumor testing services. The company was founded in 1991 and is headquartered in Salt Lake City, Utah.
Over the last 12 months, insiders at Myriad Genetics, Inc. have bought $0 and sold $7.1M worth of Myriad Genetics, Inc. stock.
On average, over the past 5 years, insiders at Myriad Genetics, Inc. have bought $563,557 and sold $8.69M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 30,000 shares for transaction amount of $498,672 was made by Phanstiel S. Louise (director) on 2020‑11‑11.
2024-06-04 | Sale | SPIEGELMAN DANIEL K | director | 3,788 0.0041% | $22.05 | $83,525 | +4.86% | |
2024-06-03 | Sale | SPIEGELMAN DANIEL K | director | 3,788 0.0041% | $22.04 | $83,488 | +4.11% | |
2024-05-15 | Sale | DIAZ PAUL J | President and CEO | 75,000 0.0843% | $25.07 | $1.88M | -5.56% | |
2024-05-14 | Sale | DIAZ PAUL J | President and CEO | 95,000 0.1043% | $25.21 | $2.39M | -8.10% | |
2024-05-13 | Sale | DIAZ PAUL J | President and CEO | 57,844 0.0644% | $25.13 | $1.45M | -6.46% | |
2024-05-13 | Sale | Newcomer Lee Nisley | director | 6,200 0.007% | $25.30 | $156,860 | -6.46% | |
2023-12-01 | Sale | Riggsbee Richard Bryan | Chief Financial Officer | 30,000 0.0333% | $19.09 | $572,835 | +12.45% | |
2023-11-01 | Sale | Riggsbee Richard Bryan | Chief Financial Officer | 30,000 0.0363% | $15.69 | $470,622 | +35.13% | |
2023-06-02 | Sale | SPIEGELMAN DANIEL K | director | 8,638 0.0104% | $23.01 | $198,760 | -13.70% | |
2023-03-27 | Sale | Lambert Nicole | Chief Operating Officer | 6,433 0.008% | $23.48 | $151,047 | -11.11% | |
2023-03-02 | Sale | Riggsbee Richard Bryan | Chief Financial Officer | 15,000 0.0182% | $22.55 | $338,253 | -9.52% | |
2023-03-02 | Sale | Lambert Nicole | Chief Operating Officer | 13,184 0.0161% | $22.74 | $299,823 | -9.52% | |
2023-01-20 | Sale | Riggsbee Richard Bryan | Chief Financial Officer | 9,400 0.0114% | $20.04 | $188,386 | -4.86% | |
2023-01-18 | Sale | Riggsbee Richard Bryan | Chief Financial Officer | 600 0.0008% | $20.01 | $12,006 | -1.32% | |
2022-12-27 | Sale | Riggsbee Richard Bryan | Chief Financial Officer | 20,000 0.0245% | $15.15 | $302,992 | +25.21% | |
2022-06-06 | Sale | SPIEGELMAN DANIEL K | 6,424 0.0082% | $19.25 | $123,673 | +7.21% | ||
2022-02-28 | Sale | Hart Jayne B. | Chief People Officer | 3,500 0.0045% | $25.00 | $87,500 | -16.57% | |
2021-10-01 | Sale | Lambert Nicole | See Remarks | 1,420 0.0018% | $31.57 | $44,835 | -21.54% | |
2021-09-27 | Sale | Lambert Nicole | See Remarks | 10,112 0.0131% | $33.10 | $334,747 | -22.72% | |
2021-09-23 | Sale | LANCHBURY JERRY S | Chief Scientific Officer | 200 0.0003% | $35.06 | $7,012 | -27.45% |
DIAZ PAUL J | President and CEO | 1066166 1.178% | $24.62 | 0 | 3 | |
Riggsbee Richard Bryan | Chief Financial Officer | 291812 0.355% | $24.62 | 0 | 8 | |
Newcomer Lee Nisley | director | 66650 0.0736% | $24.62 | 0 | 1 | |
SPIEGELMAN DANIEL K | director | 32917 0.0493% | $24.62 | 0 | 6 | |
Capone Mark Christopher | President & C.E.O. | 440833 0.5363% | $24.62 | 1 | 16 | <0.0001% |
LANCHBURY JERRY S | Chief Scientific Officer | 288515 0.351% | $24.62 | 0 | 52 | |
Lambert Nicole | Chief Operating Officer | 240506 0.2926% | $24.62 | 0 | 7 | |
HOBDEN ADRIAN N | Pres. Myriad Pharmaceuticals | 195726 0.2381% | $24.62 | 0 | 12 | |
Hart Jayne B. | Chief People Officer | 165878 0.2018% | $24.62 | 0 | 4 | |
Ford Alexander | Chief Operating Officer | 151159 0.1839% | $24.62 | 0 | 4 | |
Tobin Bernard | President Crescendo BioScience | 146040 0.1777% | $24.62 | 0 | 1 | |
King Gary A. | Exec. VP International Ops | 134871 0.1641% | $24.62 | 0 | 13 | |
CRITCHFIELD GREGORY C | President Myriad Genetic Labs | 129546 0.1576% | $24.62 | 0 | 7 | |
MARSH RICHARD M | E.V.P., General Counsel | 124197 0.1511% | $24.62 | 0 | 36 | |
McDade Ralph L | President Myriad RBM, Inc. | 122604 0.1492% | $24.62 | 1 | 1 | <0.0001% |
BEST LAWRENCE C | director | 100000 0.1217% | $24.62 | 0 | 2 | |
LANGER DENNIS | director | 89527 0.1089% | $24.62 | 0 | 16 | |
Parkinson Paul | EVP Strategy and Innovation | 76746 0.0934% | $24.62 | 0 | 1 | |
HENDERSON JOHN T | director | 64353 0.0783% | $24.62 | 5 | 9 | +11.11% |
Phanstiel S. Louise | director | 61646 0.075% | $24.62 | 1 | 2 | +79.17% |
GILBERT WALTER PHD | director | 54150 0.0659% | $24.62 | 1 | 16 | <0.0001% |
Evans James S | Chief Financial Officer | 48128 0.0586% | $24.62 | 0 | 28 | |
SKOLNICK MARK H | Chief Scientific Officer | 34000 0.0414% | $24.62 | 0 | 18 | |
DREISMANN HEINRICH | director | 33743 0.0411% | $24.62 | 0 | 4 | |
MOYES JAY M | Chief Financial Officer | 25282 0.0308% | $24.62 | 0 | 12 | |
Laslie W Wayne | Chief Operating Officer, MPI | 15082 0.0183% | $24.62 | 0 | 5 | |
HOCKETT WILLIAM A III | V. P. of Corp Communications | 9001 0.011% | $24.62 | 0 | 8 | |
MELDRUM PETER D | President & C.E.O. | 6540 0.008% | $24.62 | 0 | 53 | |
ATTIYEH ROBERT S | director | 3000 0.0036% | $24.62 | 1 | 0 | +1.92% |
WILSON LINDA S | director | 2500 0.003% | $24.62 | 0 | 4 | |
SIMON S GEORGE | V.P. Business Development | 2278 0.0028% | $24.62 | 0 | 6 | |
Belle Gerald P. | director | 1200 0.0015% | $24.62 | 1 | 0 | <0.0001% |
Harrison Robert Gardner | Chief Information Officer | 324 0.0004% | $24.62 | 0 | 12 | |
Rogers Ronald S. | Exec VP Corp Communications | 0 0% | $24.62 | 0 | 1 | |
HAYES ARTHUR HULL JR | director | 0 0% | $24.62 | 0 | 3 |
BlackRock | $317.23M | 16.44 | 14.88M | +1.51% | +$4.71M | 0.01 | |
The Vanguard Group | $213.96M | 11.09 | 10.04M | +0.82% | +$1.74M | <0.01 | |
Wellington Management Company | $171.84M | 8.9 | 8.06M | +11.64% | +$17.92M | 0.03 | |
Camber Capital Management Lp | $162.78M | 8.44 | 7.63M | 0% | +$0 | 5.74 | |
State Street | $115.21M | 5.97 | 5.4M | +14.96% | +$14.99M | 0.01 | |
Glenview Capital Management | $105.4M | 5.46 | 4.94M | -6.44% | -$7.26M | 2.05 | |
Millennium Management LLC | $86.86M | 4.5 | 4.07M | +17.7% | +$13.06M | 0.06 | |
EARNEST Partners | $83.85M | 4.35 | 3.93M | +0.49% | +$408,171.40 | 0.38 | |
Dimensional Fund Advisors | $57.6M | 2.99 | 2.7M | +0.77% | +$439,106.72 | 0.02 | |
Bank of America | $56.39M | 2.92 | 2.64M | -11.43% | -$7.27M | 0.01 | |
Artisan Partners | $54.79M | 2.84 | 2.57M | +5.6% | +$2.91M | 0.08 | |
SEI Investments Company | $48.89M | 2.53 | 2.29M | +6.1% | +$2.81M | 0.07 | |
Disciplined Growth Investors Inc Mn | $44.29M | 2.3 | 2.08M | +6.24% | +$2.6M | 0.81 | |
Geode Capital Management | $43M | 2.23 | 2.02M | +7.72% | +$3.08M | <0.01 | |
Morgan Stanley | $35.64M | 1.85 | 1.67M | +99.99% | +$17.82M | <0.01 | |
Nuveen | $30.52M | 1.58 | 1.43M | +36.33% | +$8.13M | 0.01 | |
Citadel Advisors LLC | $29.13M | 1.51 | 1.37M | +17.39% | +$4.32M | 0.02 | |
D. E. Shaw & Co. | $26.99M | 1.4 | 1.27M | -29.71% | -$11.41M | 0.04 | |
Charles Schwab | $21.03M | 1.09 | 986,466 | +6.51% | +$1.29M | 0.01 | |
Northern Trust | $20.39M | 1.06 | 956,356 | +1.51% | +$303,149.08 | <0.01 | |
Goldman Sachs | $19.35M | 1 | 907,658 | -16.57% | -$3.84M | <0.01 | |
Point72 Asset Management | $16.59M | 0.86 | 778,196 | New | +$16.59M | 0.03 | |
BNY Mellon | $14.74M | 0.76 | 691,176 | -3.34% | -$509,888.87 | <0.01 | |
Invesco | $13.02M | 0.68 | 610,653 | -13.19% | -$1.98M | <0.01 | |
State Farm | $9.51M | 0.49 | 446,061 | 0% | +$0 | 0.01 | |
Fisher Asset Management Llc | $8.28M | 0.43 | 388,347 | +145.84% | +$4.91M | <0.01 | |
Mirae Asset Global Investments Co Ltd | $7.62M | 0.37 | 334,717 | +80.46% | +$3.4M | 0.01 | |
PEREGRINE CAPITAL MANAGEMENT INC | $6.42M | 0.33 | 301,257 | +0.03% | +$1,599.00 | 0.19 | |
RhumbLine Advisers | $5.9M | 0.31 | 276,674 | +2.01% | +$116,236.15 | 0.01 | |
Citigroup | $5.69M | 0.3 | 267,106 | +123.66% | +$3.15M | 0.01 | |
Ameriprise Financial | $5.61M | 0.29 | 262,957 | -2.96% | -$170,709.26 | <0.01 | |
Legal & General | $5.34M | 0.28 | 250,512 | +4.39% | +$224,862.05 | <0.01 | |
Rafferty Asset Management Llc | $5.31M | 0.28 | 249,203 | +45.39% | +$1.66M | 0.02 | |
Natixis Advisors L P | $5.08M | 0.26 | 238,365 | +25.27% | +$1.03M | 0.01 | |
UBS | $4.48M | 0.23 | 210,269 | +24.55% | +$883,778.14 | <0.01 | |
Assenagon Asset Management S.A. | $4.22M | 0.22 | 197,711 | +49.01% | +$1.39M | 0.01 | |
Public Sector Pension Investment Board | $3.87M | 0.2 | 181,478 | -1.37% | -$53,726.40 | 0.03 | |
Swiss National Bank | $3.72M | 0.19 | 174,700 | +8.24% | +$283,556.00 | <0.01 | |
Macquarie Group | $3.13M | 0.16 | 147,038 | -1.14% | -$36,075.16 | <0.01 | |
Barclays | $3.09M | 0.16 | 145,079 | -27.17% | -$1.15M | <0.01 | |
New York State Common Retirement Fund | $2.94M | 0.15 | 137,653 | +4.37% | +$123,005.06 | <0.01 | |
State of Wisconsin Investment Board | $2.94M | 0.15 | 137,909 | +6.16% | +$170,623.97 | 0.01 | |
Wells Fargo | $2.88M | 0.15 | 135,261 | -23.21% | -$871,713.71 | <0.01 | |
Nordea Investment Management Ab | $2.77M | 0.14 | 128,903 | +5.58% | +$146,214.34 | <0.01 | |
Thrivent Financial For Lutherans | $2.48M | 0.13 | 116,323 | -1.86% | -$47,010.48 | 0.01 | |
Prudential Financial | $2.49M | 0.13 | 116,937 | +15.63% | +$336,962.62 | <0.01 | |
First Trust | $2.49M | 0.13 | 116,743 | New | +$2.49M | <0.01 | |
AllianceBernstein | $2.42M | 0.13 | 113,510 | +4.84% | +$111,716.79 | <0.01 | |
Amh Equity Ltd | $2.35M | 0.12 | 110,000 | New | +$2.35M | 2.93 | |
JPMorgan Chase | $2.24M | 0.12 | 104,874 | -29.09% | -$917,314.86 | <0.0001 |